During his more than ten years at Cabot, Michael Cintolo has uncovered exceptional growth stocks and helped to create new tools and rules for buying and selling stocks. Perhaps most notable was his development of the proprietary trend-following market timing system, Cabot Tides, which has helped Cabot place among the top investment newsletters numerous times. Cabot Growth Investor has been consistently recognized for outstanding performance by Hulbert Financial Digest and Timer Digest. It is one of Hulbert's top five newsletters for five-year risk-adjusted performance with a 13.2% annualized return as of June 30, 2011. It is also ranked among the Top Ten Newsletters by Timer Digest for long-term performance.
Biotech stocks are still in the process of repairing the damage from recent months — and recent years. Indeed, as of a month ago, the SPDR Biotech Fund (XBI) had been dead money for an unbelievable eight and a half years, asserts Mike Cintolo, editor of Cabot Growth Investor.
A tamer-than-expected inflation report cemented the idea that the Federal Reserve is on hold, and that sent the major indices higher. The rally that started Nov. 1 had been promising, and now it looks some of the flies in the ointment that remained are clearing up. Buy Nutanix (NTNX), writes Mike Cintolo, editor of Cabot Top Ten Trader.
The adoption of so-called “electronification” in the financial sector — particularly in the realm of credit trading — is being spurred by the demand for greater efficiency, suggests Mike Cintolo, growth stock expert and editor of Cabot Top Ten Trader.
There’s no question cybersecurity remains in a long-term growth phase, with the mobile and work-from-home reality, as well as AI (which will be used by defenders and hackers to advance their efforts), increasing the need for it, asserts Mike Cintolo, growth stock expert and editor of Cabot Top Ten Trader.